ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006
Hilger, R A, Kredke, S, Hedley, D, Moeller, J G, Bauer, R J, Stellberg, W, Seeber, S, Scheulen, M E, Strumberg, D
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Published in International journal of clinical pharmacology and therapeutics (01.12.2002)
Get more information
Journal Article